AMLX - Amylyx Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

AMLX is currently covered by 7 analysts with an average price target of $13.07. This is a potential upside of $4.92 (60.37%) from yesterday's end of day stock price of $8.15.

Amylyx Pharmaceuticals's activity chart (see below) currently has 36 price targets and 55 ratings on display. The stock rating distribution of AMLX is 74.19% BUY and 25.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40.46% with an average time for these price targets to be met of 163.63 days.

Highest price target for AMLX is $16, Lowest price target is $8, average price target is $10.71.

Most recent stock forecast was given by CHRIS SHIBUTANI from GOLDMAN SACHS on 10-Jul-2025.

Currently out of the existing stock ratings of AMLX, 23 are a BUY (74.19%), 8 are a HOLD (25.81%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$1.85 (22.70%)

$4

17 days ago
(10-Jul-2025)

4/8 (50%)

$2.61 (35.32%)

178

Buy

$12

$3.85 (47.24%)

1 months 10 days ago
(17-Jun-2025)

1/3 (33.33%)

$6.67 (125.14%)

188

Buy

$8

$-0.15 (-1.84%)

$7

2 months 13 days ago
(14-May-2025)

3/5 (60%)

$3.65 (83.91%)

95

Buy

$16

$7.85 (96.32%)

$12

2 months 18 days ago
(09-May-2025)

9/21 (42.86%)

$11.39 (247.07%)

292

Hold

$10

$1.85 (22.70%)

2 months 20 days ago
(07-May-2025)

1/4 (25%)

$5.13 (105.34%)

187

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is AMLX (Amylyx Pharmaceuticals) average time for price targets to be met?

On average it took 163.63 days on average for the stock forecasts to be realized with a an average price target met ratio 40.46

Which analyst has the current highest performing score on AMLX (Amylyx Pharmaceuticals) with a proven track record?

NEENA BITRITTO-GARG

Which analyst has the current lower performing score on AMLX (Amylyx Pharmaceuticals) with a proven track record?

GEOFF MEACHAM

Which analyst has the most public recommendations on AMLX (Amylyx Pharmaceuticals)?

Neena Bitritto-Garg has 11 price targets and 6 ratings on AMLX

Which analyst is the currently most bullish on AMLX (Amylyx Pharmaceuticals)?

Andrew Fein with highest potential upside - $7.85

Which analyst is the currently most reserved on AMLX (Amylyx Pharmaceuticals)?

Graig Suvannavejh with lowest potential downside - -$0.15

Amylyx Pharmaceuticals in the News

AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) on behalf of long-term stockholders following a class action complaint that was filed against Amylyx on July 1, 2025 with a Class Period from November...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?